Bliss GVS Pharma shares jump 3.72% as LIC files takeover disclosure under SEBI rules
Why did Bliss GVS Pharma Ltd shares jump today?
Bliss GVS Pharma Ltd shares surged 3.72% to trade at ₹495.0 on Tuesday at 02:31 PM. The sharp upward movement in the stock price was driven by a significant regulatory filing that boosted investor sentiment.
The reason behind the jump is a disclosure received by the stock exchange under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. This specific regulation pertains to notifications when a substantial acquisition of shares is made. In this case, the disclosure was for Life Insurance Corporation of India (LIC), the country's largest insurer and a major institutional investor.
The market interpreted LIC's move as a strong vote of confidence in the company's prospects. When a prominent and trusted investor like LIC increases its stake, it often signals to other market participants that the company has solid fundamentals and growth potential, leading to increased buying interest and the observed price rally.
What does Bliss GVS Pharma Ltd do?
Bliss GVS Pharma Ltd is engaged in the manufacture of pharmaceutical formulations. The company operates in the pharmaceutical sector, with its primary activity centered on producing finished dosage forms. Its manufacturing capabilities are focused on developing and producing a range of pharmaceutical products.
The company's product portfolio includes formulations in several therapeutic areas. These areas encompass gynaecology, anti-infective, dermatology, gastroenterology, and vitamins, minerals, and nutrients. This indicates a diversified product line targeting various segments of the healthcare market.
Bliss GVS Pharma Ltd Financials
In CroresBliss GVS Pharma Ltd showed positive growth between the December 2025 and March 2026 quarters. Revenue increased from ₹218.25 Crores to ₹256.99 Crores, reflecting a growth of approximately 17.8%. Concurrently, profit after tax also saw a significant rise, growing from ₹23.27 Crores to ₹35.58 Crores, which marks an increase of about 52.9%. This data indicates a strong upward trend in both top-line revenue and bottom-line profitability for the company during this period.
Bliss GVS Pharma Ltd Shareholding Pattern
Promoter holding stands at 35.01% of the total share capital. Foreign Institutional Investors (FIIs) hold 8.07% stake in the company, while Domestic Institutional Investors (DIIs) hold 9.46%. Public shareholders hold the remaining 47.45% stake in Bliss GVS Pharma Ltd.
Bliss GVS Pharma Ltd FAQs
Q: Why did Bliss shares jump 3.72% today?
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Bliss GVS Pharma Ltd?
As per the latest data, promoters hold 35.01% stake in Bliss GVS Pharma Ltd, while FII holding stands at 8.07%. Domestic institutional investors hold 9.46%, and public shareholders account for 47.45% of the equity.
Q: What is the current stock price of Bliss GVS Pharma Ltd?
Bliss GVS Pharma Ltd shares are currently trading at ₹495.0, recording a gain of 3.72% from the previous close.
Q: What is the market capitalization of Bliss GVS Pharma Ltd?
The company currently has a market capitalization of ₹5249.78 crore, reflecting its valuation in the Indian equity market.